Genomics Center of Innovation
Waters has recognized the Center for Proteomics at the Translational Genomics Research Institute, in Phoenix, Arizona, USA, as a Waters Center of Innovation. In particular the company recognized the work of Dr Konstantinos Petritis, head of the centre, and his team for their leadership in the research of proteomics and biomarker discovery and verification.
Waters has recognized the Center for Proteomics at the Translational Genomics Research Institute, in Phoenix, Arizona, USA, as a Waters Center of Innovation. In particular the company recognized the work of Dr Konstantinos Petritis, head of the centre, and his team for their leadership in the research of proteomics and biomarker discovery and verification.
“Whether it’s through our discovery-based research or clinical programmes, our focus is to provide patient benefit as quickly as we can”, said Dr Jeffrey Trent, the institute’s president and research director. “My hope and expectation is that in many unique ways the Waters’ Centers of Innovation Program will help us accelerate our research and further our goal of providing personalized medicine to each patient in the future”.
“One of our core strengths is in biomarker discovery and verification”, said Dr Petritis. “With the infrastructure we’ve put into place, we are making steady progress in the development of diagnostic and prognostic biomarkers for lung, colon, breast and pancreatic cancer as well as other diseases. We’re thankful to Waters for their support of our programmes, not just in terms of instrumentation, but in terms of their training, technical support and services.”
For more information on the programme visit www.waters.comThis story originally appeared in The Column. Click here to view that issue.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
